Nina Lindblom

464 total citations
11 papers, 355 citations indexed

About

Nina Lindblom is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, Nina Lindblom has authored 11 papers receiving a total of 355 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Cellular and Molecular Neuroscience and 5 papers in Physiology. Recurrent topics in Nina Lindblom's work include Neurotransmitter Receptor Influence on Behavior (6 papers), Nicotinic Acetylcholine Receptors Study (5 papers) and Smoking Behavior and Cessation (5 papers). Nina Lindblom is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (6 papers), Nicotinic Acetylcholine Receptors Study (5 papers) and Smoking Behavior and Cessation (5 papers). Nina Lindblom collaborates with scholars based in Sweden, Denmark and United Kingdom. Nina Lindblom's co-authors include Genadiy Kalayanov, Anette M. Johansson, Sandra Gordon, T.H. Svensson, Torgny H. Svensson, George G. Nomikos, P. Hertel, Serena Tonstad, Stephanie de Villiers and K.O. Fagerström and has published in prestigious journals such as Nature Medicine, Diabetes Care and Psychopharmacology.

In The Last Decade

Nina Lindblom

11 papers receiving 343 citations

Peers

Nina Lindblom
Dan E. Keyler United States
Megan Laudenbach United States
Carly Baehr United States
Stephen Ramage United Kingdom
Marilou A. Andres United States
Wagner Hn United States
Dan E. Keyler United States
Nina Lindblom
Citations per year, relative to Nina Lindblom Nina Lindblom (= 1×) peers Dan E. Keyler

Countries citing papers authored by Nina Lindblom

Since Specialization
Citations

This map shows the geographic impact of Nina Lindblom's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nina Lindblom with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nina Lindblom more than expected).

Fields of papers citing papers by Nina Lindblom

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nina Lindblom. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nina Lindblom. The network helps show where Nina Lindblom may publish in the future.

Co-authorship network of co-authors of Nina Lindblom

This figure shows the co-authorship network connecting the top 25 collaborators of Nina Lindblom. A scholar is included among the top collaborators of Nina Lindblom based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nina Lindblom. Nina Lindblom is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Krogvold, Lars, Nina Lindblom, Jacob Westman, et al.. (2025). Three-Year Follow-up After Antiviral Treatment in New-Onset Type 1 Diabetes: Results From the Diabetes Virus Detection and Intervention Trial. Diabetes Care. 48(3). 481–488. 2 indexed citations
2.
Krogvold, Lars, Erica Ponzi, Nina Lindblom, et al.. (2023). Pleconaril and ribavirin in new-onset type 1 diabetes: a phase 2 randomized trial. Nature Medicine. 29(11). 2902–2908. 29 indexed citations
3.
Lindblom, Nina, Lars Lindquist, Jacob Westman, et al.. (2021). Potential Virus Involvement in Alzheimer’s Disease: Results from a Phase IIa Trial Evaluating Apovir, an Antiviral Drug Combination. Journal of Alzheimer s Disease Reports. 5(1). 413–431. 13 indexed citations
4.
Tonstad, Serena, Philip Tønnesen, Nina Lindblom, et al.. (2013). Niccine(R), a Nicotine Vaccine, for Relapse Prevention: A Phase II, Randomized, Placebo-Controlled, Multicenter Clinical Trial. Nicotine & Tobacco Research. 15(9). 1492–1501. 55 indexed citations
5.
Lindblom, Nina, Genadiy Kalayanov, Sandra Gordon, et al.. (2010). Nicotine hapten structure, antibody selectivity and effect relationships: Results from a nicotine vaccine screening procedure. Vaccine. 28(10). 2161–2168. 39 indexed citations
6.
Lindblom, Nina, Svetlana Semenova, Genadiy Kalayanov, et al.. (2005). Active immunisation against nicotine blocks the reward facilitating effects of nicotine and partially prevents nicotine withdrawal in the rat as measured by dopamine output in the nucleus accumbens, brain reward thresholds and somatic signs. Naunyn-Schmiedeberg s Archives of Pharmacology. 372(3). 182–194. 16 indexed citations
7.
Lindblom, Nina, et al.. (2004). Active immunization against nicotine alters the distribution of nicotine but not the metabolism to cotinine in the rat. Naunyn-Schmiedeberg s Archives of Pharmacology. 370(4). 299–304. 25 indexed citations
8.
Lindblom, Nina, et al.. (2002). Active Immunization against Nicotine Prevents Reinstatement of Nicotine-Seeking Behavior in Rats. Respiration. 69(3). 254–260. 80 indexed citations
9.
Lindblom, Nina, et al.. (2002). Active Immunization against Nicotine Suppresses Nicotine-Induced Dopamine Release in the Rat Nucleus accumbens Shell. Respiration. 69(3). 247–253. 62 indexed citations
10.
Hertel, P., Nina Lindblom, George G. Nomikos, & Torgny H. Svensson. (2000). Receptor-mediated regulation of serotonin output in the rat dorsal raphe nucleus: effects of risperidone. Psychopharmacology. 153(3). 307–314. 14 indexed citations
11.
Hertel, P., Nina Lindblom, George G. Nomikos, & Torgny H. Svensson. (1998). Modulation of central serotonergic neurotransmission by risperidone: Underlying mechanism(s) and significance of action. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 22(5). 815–834. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026